CAV1 and breast neoplasm: In addition, caveolin-1 mutations have now been detected: Hayashi et al. [194] identified heterozygous mutations in codon 132 (P132L) of caveolin-1 in 16% of human primary breast tumours examined, while failing to observe this mutation in test subjects.